Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Franklin Cockerill, Stephen Suffin, Arthur Levinson

Premium

Quest Diagnostics announced that Franklin Cockerill, III, is its new VP and chief laboratory officer as of Oct. 1. Cockerill was most recently CEO of Mayo Medical Laboratories and served as the chair of laboratory medicine and pathology for the Mayo Clinic. He has held several leadership positions, including chairing the Microbiology Devices Panel of the US Food and Drug Administration’s Medical Devices Advisory Committee; serving as an editor of the Journal of Clinical Microbiology; and serving as a program chair and board member of the Association for Molecular Pathology.

At Quest, Cockerill will oversee Quest’s lab network and lead the firm’s medical affairs strategies, and academic and government collaborations. He will replace Stephen Suffin, who is retiring at the end of the year but will continue to consult through 2015.


Roche announced that Arthur Levinson has resigned from its board of directors, effective immediately. The drugmaker said Levinson, who was chairman and CEO at Genentech from 1999 to 2014, made the decision to avoid any conflict with his post as CEO at Calico, a Google-backed startup. Levinson has served on Roche's board since 2010.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.